Replies to post #351173 on Amarin Corp Plc (AMRN)

[Number sleven]

Ralphey, I wouldn't be overly concerned. Phase 2. They would need to run an successful outcome study to get CVD approval. That takes years.
Sleven,

[ggwpq]

The reason I posted the link is to show that PFE is still interested in statin add-on/cardiovascular market and if the Vupanorsen trial failed, PFE would definitely BO AMRN.

[ramfan60]

I think "occam's razor" applies here...... I think Pfizer has an interest in Vascepa and it's potential. This is an easy test for them to see if their team can increase the market penetration for this drug. They are making those sales calls anyway so why not get a little compensation and at the same time, if they are very successful, they know they have the secret sauce strategy to sell this drug. That opens things up for a global play. That play could be what we are all hoping for.

[Gussettville]

Looks like a possible trig lowering drug. This is not where the action is for Vascepa and CVD prevention.

The magic of Vascepa lies in it’s anti inflammatory properties. Fairly confident trig lowering is just a bystander.